Category: Index Fund |
Launch Date: 14-12-2022 |
Asset Class: |
Benchmark: NIFTY Pharma TRI |
Expense Ratio: 0.97% As on ( 31-03-2025) |
Status: Open Ended Schemes |
Minimum Topup: 1000.0 |
Total Assets: 80.6 Cr As on ( 31-03-2025) |
Turn over: 180 |
Kayzad Eghlim, Nishit Patel, Kewal Shah, Priya Sridhar
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index